|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0045093,
umls-concept:C0205179,
umls-concept:C0205195,
umls-concept:C0231441,
umls-concept:C0235974,
umls-concept:C0443218,
umls-concept:C0574032,
umls-concept:C1446539,
umls-concept:C1512044,
umls-concept:C2827483
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-7-3
|
|
pubmed:abstractText |
Gemcitabine is currently considered the standard treatment for advanced pancreatic cancer (APC). Cisplatin and a fluoropyrimidine have some activity in the treatment of this cancer. The aim of this trial is to evaluate the efficacy and toxicity of a fixed dose-rate infusion of gemcitabine associated with cisplatin and UFT in patients with APC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
pubmed-author:BarónM GonzálezMG,
pubmed-author:CasadoEE,
pubmed-author:CastañónCC,
pubmed-author:CastroJJ,
pubmed-author:CruzMM,
pubmed-author:FeliuJJ,
pubmed-author:FonsecaEE,
pubmed-author:JaráizA RodríguezAR,
pubmed-author:JaraCC,
pubmed-author:LeónAA,
pubmed-author:LomasMM,
pubmed-author:SáenzJ GarcíaJG
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
419-26
|
|
pubmed:meshHeading |
pubmed-meshheading:16404636-Adult,
pubmed-meshheading:16404636-Aged,
pubmed-meshheading:16404636-Antimetabolites, Antineoplastic,
pubmed-meshheading:16404636-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16404636-Cisplatin,
pubmed-meshheading:16404636-Deoxycytidine,
pubmed-meshheading:16404636-Female,
pubmed-meshheading:16404636-Humans,
pubmed-meshheading:16404636-Male,
pubmed-meshheading:16404636-Middle Aged,
pubmed-meshheading:16404636-Pain Measurement,
pubmed-meshheading:16404636-Pancreatic Neoplasms,
pubmed-meshheading:16404636-Tegafur,
pubmed-meshheading:16404636-Treatment Outcome,
pubmed-meshheading:16404636-Uracil
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Fixed dose-rate infusion of gemcitabine in combination with cisplatin and UFT in advanced carcinoma of the pancreas.
|
|
pubmed:affiliation |
Servicio de Oncología Médica, Hospital La Paz, Paseo de la Castellana, 261, 28046, Madrid, Spain. jfeliu.hulp@salud.madrid.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
